IntraLinks
® (NYSE: IL), a global technology provider of inter-enterprise content management and collaboration solutions, announced that
Actelion Pharmaceuticals Ltd
, an Allschwil/Basel, Switzerland headquartered biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments to serve unmet medical needs, has selected IntraLinks Connect℠ to streamline its documentation exchange during clinical trials.
Prior to engaging IntraLinks, Actelion relied on traditional courier services to facilitate the exchange of sensitive clinical trial documentation between sponsors and participants, resulting in excessive shipping costs and manual processes for tracking and other activities.
To streamline its documentation process and gain efficiency for themselves and their investigators, Actelion chose IntraLinks Connect to provide central clinical trial portals to facilitate the more secure, compliant auditable exchange of site feasibility, study start up, study conduct and study close-out documentation.
IntraLinks Connect’s security, detailed reporting, workflows, and analytics, together with IntraLinks’ knowledgeable professional service support convinced Actelion that IntraLinks provided the best fit to its requirements. “Whilst working with IntraLinks we can see the maturity of its technology and the commitment of the team to support Actelion moving forward in this area,” said Christine Schwenninger, Head of Global Clinical Monitoring, Actelion. “We are looking forward to working closely together with IntraLinks in the coming years.”
“Actelion’s engagement of IntraLinks demonstrates the growing demand for secure information exchange within the clinical trial process,” says Andy Watson, VP of life sciences EMA at IntraLinks. “IntraLinks Connect will provide Actelion greater efficiency, traceability, and security to improve communication, collaboration, and document exchange between everyone involved in the clinical trial.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.